https://news.medxy.ai/pcsk9-inhibition-lowers-ldl-cholesterol-in-heterozygous-familial-hypercholesterolemia-regardless-of-ldl-receptor-variant-function/Medxy AIen2026-05-03T12:47:16-07:00PCSK9 Inhibition Lowers LDL Cholesterol in Heterozygous Familial Hypercholesterolemia Regardless of LDL Receptor Variant Function https://news.medxy.ai/development-and-validation-of-a-clinical-polygenic-risk-report-in-u-s-based-health-systems-for-8-cardiovascular-conditions/Medxy AIen2026-05-02T22:18:57-07:00Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions https://news.medxy.ai/glp-1-receptor-agonists-show-lower-heart-failure-risk-versus-dpp-4-inhibitors-in-type-2-diabetes/Medxy AIen2026-05-02T21:35:58-07:00GLP-1 Receptor Agonists Show Lower Heart Failure Risk Versus DPP-4 Inhibitors in Type 2 Diabetes